NEW HAVEN, Conn. and SAN FRANCISCO, May 2, 2023 /PRNewswire/ -- Arvinas, Inc. (Nasdaq: ARVN) and Quantum Leap Healthcare Collaborative™ today announced that Arvinas' vepdegestrant (ARV-471), a novel PROTAC® estrogen receptor (ER) protein degrader being co-developed with Pfizer Inc. will...
News Ticker
- [ May 29, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomic – Carnegie Institution for Science – Stanford, CA San Francisco Biotech Jobs
- [ May 29, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution for Science – Stanford, CA San Francisco Biotech Jobs
- [ May 29, 2023 ] Sales Representative – Biotech – Selleck Chemicals LLC – San Francisco, CA San Francisco Biotech Jobs
- [ May 29, 2023 ] Sales Associate – Biotech – Selleck Chemicals LLC – Stanford, CA San Francisco Biotech Jobs
- [ May 28, 2023 ] Senior Manager, Quality Control Clinical Programs and LIMS Administration – Aimmune Therapeutics – Brisbane, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
